For information concerning this clinical site, please contact Nymox at 800-936-9669.

Lancaster, Pennsylvania 17604

0 studies enrolling now · 2 studies all time

What they study most

Benign Prostatic Hyperplasia

Studies at this site

• Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) — Completed
• Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) — Completed